• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用低负荷临床数据识别痴呆症神经病理学

Identifying dementia neuropathology using low-burden clinical data.

作者信息

Ren Yueqi, Shahbaba Babak, Stark Craig E L

机构信息

Medical Scientist Training Program, School of Medicine, University of California Irvine, Irvine, California, USA.

Department of Statistics, Donald Bren School of Information and Computer Sciences, University of California Irvine, Irvine, California, USA.

出版信息

Alzheimers Dement. 2025 Aug;21(8):e70539. doi: 10.1002/alz.70539.

DOI:10.1002/alz.70539
PMID:40760979
Abstract

INTRODUCTION

Identifying dementia neuropathology is critical for guiding effective therapies and clinical trials. To tackle this, we developed semi-supervised models for identifying neuropathology using low-burden data to improve generalizability.

METHODS

We defined low-burden data as being reasonably obtainable at a primary care setting. By using a semi-supervised learning paradigm, we can amplify the utility of low-burden data. We trained a clustering and a semi-supervised prediction model to yield clustering and prediction results for different neuropathology lesion types.

RESULTS

Our clustering model identified two clinically meaningful outlier groups that were either neuropathology-enriched or -scarce. We predicted neuropathology burden across different pathology types and found that using low-burden data over multiple clinical visits can predict neuropathology on par with using higher-burden data.

DISCUSSION

This work fills a critical gap in the field by using low-burden clinical data to predict neuropathology, thereby improving dementia screening, therapy, and targeted clinical trials.

HIGHLIGHTS

Clinical data are useful for neuropathology screening in future clinical trials. Novel application of semi-supervised learning for identifying neuropathology. Clustering model found groups with highly different neuropathology prevalence. Low-burden data can provide relatively accurate predictions of pathology load. Higher-burden, longitudinal data are most helpful for predicting vascular lesions.

摘要

引言

识别痴呆症神经病理学对于指导有效治疗和临床试验至关重要。为了解决这一问题,我们开发了半监督模型,利用低负荷数据识别神经病理学,以提高通用性。

方法

我们将低负荷数据定义为在初级保健机构中能够合理获取的数据。通过使用半监督学习范式,我们可以扩大低负荷数据的效用。我们训练了一个聚类模型和一个半监督预测模型,以生成不同神经病理学病变类型的聚类和预测结果。

结果

我们的聚类模型识别出两个具有临床意义的异常组,一组富含神经病理学特征,另一组则较少。我们预测了不同病理类型的神经病理学负担,发现通过多次临床就诊使用低负荷数据能够与使用高负荷数据一样预测神经病理学情况。

讨论

这项工作通过使用低负荷临床数据预测神经病理学,填补了该领域的一个关键空白,从而改善痴呆症筛查、治疗和靶向临床试验。

要点

临床数据在未来临床试验的神经病理学筛查中很有用。半监督学习在识别神经病理学方面的新应用。聚类模型发现了神经病理学患病率差异很大的组。低负荷数据可以提供相对准确的病理负荷预测。高负荷的纵向数据对预测血管病变最有帮助。

相似文献

1
Identifying dementia neuropathology using low-burden clinical data.利用低负荷临床数据识别痴呆症神经病理学
Alzheimers Dement. 2025 Aug;21(8):e70539. doi: 10.1002/alz.70539.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
4
Exercise programs for people with dementia.针对痴呆症患者的运动项目。
Cochrane Database Syst Rev. 2013 Dec 4(12):CD006489. doi: 10.1002/14651858.CD006489.pub3.
5
Personally tailored activities for improving psychosocial outcomes for people with dementia in long-term care. 为长期护理机构中的痴呆症患者制定个性化的活动以改善其心理社会结局。
Cochrane Database Syst Rev. 2023 Mar 13;3(3):CD009812. doi: 10.1002/14651858.CD009812.pub3.
6
Music-based therapeutic interventions for people with dementia.针对痴呆症患者的基于音乐的治疗干预措施。
Cochrane Database Syst Rev. 2025 Mar 7;3(3):CD003477. doi: 10.1002/14651858.CD003477.pub5.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Clinical judgement by primary care physicians for the diagnosis of all-cause dementia or cognitive impairment in symptomatic people.初级保健医生对有症状人群进行全因痴呆或认知障碍诊断的临床判断。
Cochrane Database Syst Rev. 2022 Jun 16;6(6):CD012558. doi: 10.1002/14651858.CD012558.pub2.
9
Personally tailored activities for improving psychosocial outcomes for people with dementia in long-term care.为长期护理中的痴呆症患者改善心理社会状况而量身定制的活动。
Cochrane Database Syst Rev. 2018 Feb 13;2(2):CD009812. doi: 10.1002/14651858.CD009812.pub2.
10
Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.胆碱酯酶抑制剂治疗血管性痴呆和其他血管性认知障碍:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Feb 22;2(2):CD013306. doi: 10.1002/14651858.CD013306.pub2.

本文引用的文献

1
Exploring the power of MRI and clinical measures in predicting AD neuropathology.探索磁共振成像(MRI)和临床测量在预测阿尔茨海默病神经病理学方面的作用。
Geroscience. 2025 Apr 8. doi: 10.1007/s11357-025-01645-2.
2
Developing and validating a prediction tool for cerebral amyloid angiopathy neuropathological severity.开发并验证一种用于脑淀粉样血管病神经病理学严重程度的预测工具。
Alzheimers Dement. 2025 Mar;21(3):e14583. doi: 10.1002/alz.14583.
3
Cognitive modeling of the Mnemonic Similarity Task as a digital biomarker for Alzheimer's disease.
作为阿尔茨海默病的数字生物标志物,对记忆相似性任务的认知建模。
Alzheimers Dement. 2024 Oct;20(10):6935-6947. doi: 10.1002/alz.14163. Epub 2024 Sep 6.
4
Comprehensive assessment of TDP-43 neuropathology data in the National Alzheimer's Coordinating Center database.全面评估国家阿尔茨海默病协调中心数据库中的 TDP-43 神经病理学数据。
Acta Neuropathol. 2024 Jun 19;147(1):103. doi: 10.1007/s00401-024-02728-8.
5
2024 Alzheimer's disease facts and figures.2024 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2024 May;20(5):3708-3821. doi: 10.1002/alz.13809. Epub 2024 Apr 30.
6
Biomarker-based staging of Alzheimer disease: rationale and clinical applications.基于生物标志物的阿尔茨海默病分期:原理与临床应用。
Nat Rev Neurol. 2024 Apr;20(4):232-244. doi: 10.1038/s41582-024-00942-2. Epub 2024 Mar 1.
7
Improving clinical efficiency in screening for cognitive impairment due to Alzheimer's.提高阿尔茨海默病所致认知障碍筛查的临床效率。
Alzheimers Dement (Amst). 2023 Oct 29;15(4):e12494. doi: 10.1002/dad2.12494. eCollection 2023 Oct-Dec.
8
Identifying individuals with non-Alzheimer's disease co-pathologies: A precision medicine approach to clinical trials in sporadic Alzheimer's disease.识别伴有非阿尔茨海默病共病的个体:在散发性阿尔茨海默病临床试验中的精准医学方法。
Alzheimers Dement. 2024 Jan;20(1):421-436. doi: 10.1002/alz.13447. Epub 2023 Sep 4.
9
Prediction of neuropathologic lesions from clinical data.从临床数据预测神经病理学病变。
Alzheimers Dement. 2023 Jul;19(7):3005-3018. doi: 10.1002/alz.12921. Epub 2023 Jan 21.
10
Mid- and later-life risk factors for predicting neuropathological brain changes associated with Alzheimer's and vascular dementia: The Honolulu Asia Aging Study and the Age, Gene/Environment Susceptibility-Reykjavik Study.中老年期风险因素预测与阿尔茨海默病和血管性痴呆相关的神经病理学脑改变:檀香山亚洲老龄化研究和年龄、基因/环境易感性雷克雅未克研究。
Alzheimers Dement. 2023 May;19(5):1705-1713. doi: 10.1002/alz.12762. Epub 2022 Oct 4.